Gembine 1 gm/vial (IV Infusion)
1 gm vial: ৳ 5,500.00
Medicine Details
Category | Details |
---|---|
Generic | Gemcitabine |
Company | Healthcare pharmaceuticals ltd |
Also available as |
Indications
- Non-Small Cell Lung Cancer
- Pancreatic Cancer
- Bladder Cancer
- Breast Cancer
- Ovarian Cancer
Pharmacology
- Metabolism by nucleoside kinases
- Inhibition of DNA synthesis
- Inhibition of ribonucleotide reductase
- Competes with dCTP for DNA incorporation
- Induction of apoptosis
Dosage & Administration
- Dosing regimens for different cancers
- Intravenous infusion instructions
- Recommended doses based on cancer type
- Dosage reduction with toxicity
Interaction
- No confirmed drug interactions reported
- No specific drug interaction studies conducted
Contraindications
- Hypersensitivity to Gemcitabine
Side Effects
- Haematological Toxicity
- Hepatic Toxicity
- Gastrointestinal toxicity
- Genito-Urinary Toxicity
- Pulmonary Toxicity
- Allergic Toxicity
- Neurotoxicity
- Alopecia
Pregnancy & Lactation
- Pregnancy Category D
- Unknown excretion in human breast milk
Precautions & Warnings
- Caution in patients with specific risks
- Schedule-dependent Toxicity
- Myelosuppression
- Pulmonary Toxicity
- Respiratory Failure
- Hemolytic Uremic Syndrome
- Embryofetal Toxicity
- Radiation Therapy Toxicity
- Impairment of Fertility
Use in Special Populations
- Elderly Patients
- Renal and Hepatic Impairment
- Children
Overdose Effects
- No known antidote for overdoses
- Principal toxicities of overdose
Therapeutic Class
- Cytotoxic Chemotherapy
Storage Conditions
- Temperature and light-sensitive storage
- Avoid refrigeration
- Keep out of the reach of children
Related Brands
- Gembine 200 mg/vial (IV Infusion) - healthcare-pharmaceuticals-ltd
- Gitabin 1 gm/vial (IV Infusion) - bots-pvt-limited
- Gemzar 1 gm/vial (IV Infusion) - eli-lilly-and-company
- Gemoxen 1 gm/vial (IV Infusion) - beacon-pharmaceuticals-plc
- Gemcitabine PhaRes 1 gm/vial (IV Infusion) - thymoorgan-pharmazie-gmbh-germany